Stocktoria

USANA HEALTH SCIENCES INC USNA

NYSE · stock · Medicinal Chemicals & Botanical Products · website · IPO 1993-10-28 · LEI

USANA HEALTH SCIENCES INC statistics & valuation

Market cap$351.0M
P / E32.6×
P / S0.4×
P / B0.7×
P / FCF41.2×
Net margin1.2%
Return on equity2.0%
FCF margin0.9%
Return on capital6.1%
Graham number +42.9%$19.35

Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else from the latest financial reports. The Graham number is Benjamin Graham's rough maximum fair value ($19.35); a green figure means the price is below it.

Profitability & efficiency

Net margin (%)
9.90% 6.00% 10.60% 9.50% 11.00% 9.80% 6.90% 6.90% 4.90% 1.20% 2016201720182019202120222022202320242026
Gross margin (%)
82.10% 82.90% 83.10% 82.30% 81.60% 81.60% 80.60% 80.80% 81.10% 78.30% 2016201720182019202120222022202320242026
Operating margin (%)
13.80% 12.70% 15.80% 13.80% 15.60% 14.30% 10.80% 10.10% 7.80% 4.00% 2016201720182019202120222022202320242026
Return on equity (%)
30.80% 17.20% 32.30% 28.60% 28.20% 29.50% 16.00% 12.80% 7.90% 2.00% 2016201720182019202120222022202320242026
Shares outstanding
25.0M 24.7M 24.6M 22.8M 21.3M 20.3M 19.3M 19.3M 19.2M 18.6M 2016201720182019202120222022202320242026
Net debt ($)
2016201720182019202120222022202320242026
Share buybacks ($)
2016201720182019202120222022202320242026
Return on assets (%)
21.30% 12.00% 22.80% 19.40% 19.50% 20.20% 11.60% 10.10% 5.60% 1.40% 2016201720182019202120222022202320242026
Free cash flow margin (%)
10.40% 10.60% 11.80% 10.40% 12.80% 9.10% 9.40% 6.10% 6.00% 0.90% 2016201720182019202120222022202320242026
Debt / equity (×)
2016201720182019202120222022202320242026
EPS ($)
$3.99 $2.53 $5.12 $4.41 $5.86 $5.73 $3.59 $3.30 $2.19 $0.58 2016201720182019202120222022202320242026

Margins and returns computed from annual filings. Falling shares outstanding = buybacks; rising = dilution. Net debt = debt − cash (negative = net cash).

P / E vs its own history

USANA HEALTH SCIENCES INC trades at about 23.3× earnings — above its 10-year norm (10-year range 14×–37.4×, median 16.3×).

14× 37.4×

Shaded band = 10-year range (14×–37.4×); dot = today's 23.3×.

Historical P/E = month-end price near each fiscal year-end ÷ that year's EPS. A read on whether the stock is cheap or dear relative to how it has typically been valued — not a forecast.

Key ratios (by fiscal year)

RatioFY2026FY2024FY2023FY2022FY2022FY2021FY2019FY2018FY2017FY2016
Gross margin78.3%81.1%80.8%80.6%81.6%81.6%82.3%83.1%82.9%82.1%
Operating margin4.0%7.8%10.1%10.8%14.3%15.6%13.8%15.8%12.7%13.8%
Net margin1.2%4.9%6.9%6.9%9.8%11.0%9.5%10.6%6.0%9.9%
FCF margin0.9%6.0%6.1%9.4%9.1%12.8%10.4%11.8%10.6%10.4%
Return on assets1.4%5.6%10.1%11.6%20.2%19.5%19.4%22.8%12.0%21.3%
Return on equity2.0%7.9%12.8%16.0%29.5%28.2%28.6%32.3%17.2%30.8%
Current ratio2.242.003.522.672.272.532.422.642.412.01

Computed from company filings · US · as of 2026-01-03. Facts plus Stocktoria's own computed scores — not investment advice.